Filtrer par catégorie
- Tous
- Congress
- Blog
- Congrès
- Ressource Scientifique
- Webinaire
- Poster
- Publication scientifique
- Communiqué de Presse
- Couverture presse
- Actualités
Filtrer par catégorie
Publication scientifique
04/09/2021
Nafamostat-Interferon-α Combination Suppresses SARS-CoV-2 Infection In Vitro and In Vivo by Cooperatively Targeting Host TMPRSS2
SARS-CoV-2; antiviral drug combination; broad-spectrum antivirals; interferon-alpha; nafamostat.
Publication scientifique
01/09/2021
[18F]FMISO PET/CT imaging of hypoxia as a non-invasive biomarker of disease progression and therapy efficacy in a preclinical model of pulmonary fibrosis: comparison with the [18F]FDG PET/CT approach.
Hypoxia; Lung fibrosis; PET/CT; [18F]FDG; [18F]FMISO.
Poster
26/08/2021
Discovery of Novel Inhibitors of PIM-1 Kinase Enabled by Generative AI
Use generative AI to generate and identify new PIM-1 kinase inhibitor hits with activity, freedom-to-operate, and good in vitro ADME properties.
Communiqué de Presse
05/07/2021
Oncodesign announces the appointment of Aline Aubertin as an independent director of the Board of Directors
Oncodesign strenghens its Board by appointing Aline Aubertin as new independent director.
Actualités
02/07/2021
Our brand Oncodesign
Our brand Oncodesign . Combination of the words oncology and design... Precision Medicine for patient... Oncodesign Services
Actualités
02/07/2021
Find out how we built our logo!
Oncodesign Services Find out how we built our logo! trajectory DNA innovation...green and bleue pharma colors Find out how we built our logo!
Communiqué de Presse
01/07/2021
Oncodesign, Covalab, CheMatech and ABX-CRO launch DRIVE™-MRT
Discover the alliance of experts in radiopharmaceuticals: an innovative offer in therapeutic development in nuclear medicine from the validation of therapeutic targets, the generation of radiolabeled biological vectors, the optimization of leads, the generation of drug candidates to IND, the design and management of clinical trials.
Actualités
01/07/2021
Brand new logo for Oncodesign
Brand new logo for Oncodesign. New graphic identity with evolutive look & feel approach... First element of our new logo.
Communiqué de Presse
28/06/2021
Oncodesign launches its new DRIVE-MRT™ service offer in partnership with Covalab, CheMatech and ABX-CRO
[Press Release] Explore our brand new service offer DRIVE-MRT. it allows the rationalization, design and optimization of targeted radiopharmaceutical products that are effective against certain metastatic cancers.
Communiqué de Presse
24/06/2021
Oncodesign provides an update on its progress on RIPK2
[Press Release] Find the update of the RIPK2 program and the start of new programs associated with Nanocyclix.
Communiqué de Presse
14/06/2021
Parkinson’s disease: Servier x Oncodesign announce the selection of a preclinical candidate
Read Press Release the selection of a preclinical candidate resulting from their strategic collaboration to find new treatments for Parkinson’s disease.
Publication scientifique
12/06/2021
Inhibiting Endothelial Cell Function in Normal and Tumor Angiogenesis Using BMP Type I Receptor Macrocyclic Kinase Inhibitors
Inhibiting Endothelial Cell Function in Normal and Tumor Angiogenesis Using BMP Type I Receptor Macrocyclic Kinase Inhibitors